From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
 | Active AAV | Inactive AAV | Healthy controls | p-value (respectively) | |||
---|---|---|---|---|---|---|---|
median | IQR | median | IQR | median | IQR | ||
Tissue factor | 265 | 247 | 174 | 107 | 105 | 84,5 | p < 0.01* p < 0.001** |
NETs | 112 | 24 | 103 | 18 | 44 | 35 | p < 0.05* p < 0.0001** p < 0.001*** |
Pentraxin3 | 1332 | 1810 | 347 | 294,5 | 184 | 146,5 | p < 0.01* p < 0.0001** ns*** |
HMGB1 | 684 | 452,5 | 380 | 258 | 77 | 61,5 | p < 0.01* p < 0.001** p < 0.001*** |
TWEAK | 131 | 83 | 141 | 102,5 | 67 | 53 | ns* p < 0.0001** p < 0.05*** |
Plasminogen | 86 | 23 | 89 | 23 | 44 | 33,5 | ns* p < 0.001** p < 0.01*** |
C3a | 201 | 91 | 147 | 87 | 89 | 72 | ns* p < 0.001** p < 0.05*** |
C5a | 131 | 86,5 | 111 | 65 | 51 | 30 | ns* p < 0.001** p < 0.01*** |